IL-1 receptor antagonist, MIS-C, and the peculiar autoimmunity of SARS-CoV-2.

Bassiri, Hamid; Canna, Scott W

Bassiri, Hamid; Canna, Scott W.

Bassiri H; Infectious Diseases, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Canna SW; Immune Dysregulation, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.

Lancet Rheumatol ; 4(5): e305-e307, 2022 May.

Article in English | MEDLINE | ID: covidwho-1764079

Fulltext

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963768
https://dx.doi.org/10.1016/S2665-9913(22)00090-X

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Lancet Rheumatol Year: 2022 Document Type: Article Affiliation country: S2665-9913(22)00090-X

Similar

MEDLINE

LILACS

LIS

Fulltext

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963768
https://dx.doi.org/10.1016/S2665-9913(22)00090-X

XML

PubMed Links

Search on Google